CHIMERIC THERAPEUTICS LIMITED - Charts / Financials

11.1%

0.5¢

Market Cap $10.07M

Healthcare Biotechnology

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company,... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company, focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its diversified portfolio includes first-in-class autologous CAR T cell therapies and allogeneic natural killer (NK) cell therapies. Its assets are being developed across multiple different disease areas in oncology with four clinical stage programs. Its pipeline includes CHM CDH17, CHM CLTX and CHM CORE NK platform. CHM CDH17 is a third-generation CDH17 CAR T, which is in phase I/II clinical trial in gastrointestinal and neuroendocrine tumors. CHM CORE-NK is a clinically validated NK cell platform in phase IB clinical trials investigating CORE-NK in combination regimens. CHM CLTX is a novel CAR-T therapy developed for the treatment of patients with solid tumors. CLTX CAR T is in phase IB clinical trial in recurrent/progressive glioblastoma. It is also building a Cell therapy portfolio.More

Day
Open	0.5¢		Day High	0.5¢		Day Low	0.4¢
Daily Volume	7556431

Bids		Sellers
Number	Price	Volume		Number	Price	Volume
32	0.4¢	22352035		14	0.5¢	14512739

Directors & Senior Management

Mr. Paul Hopper	Executive Chairman of the Board, Founder
Mr. Phillip Hains	Chief Financial Officer, Joint Company Secretary, Director
Dr. Rebecca Mcqualter	Chief Operating Officer
Dr. Eliot Bourk	Chief Business Officer
Dr. Jason B. Litten	Chief Medical Officer
Mr. Nathan Jong	Joint Company Secretary
Dr. Lesley Russell	Non-Executive Director
Mr. Eric M. Sullivan	Non-Executive Director

Data source: Refinitiv

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.5¢		Change 0.001(11.1%)		Mkt cap ! $10.07M

Open	High	Low	Value	Volume
0.5¢	0.5¢	0.4¢	$36.69K	7.556M

Buyers (Bids)

No.	Vol.	Price($)
32	22352035	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	14512739	14

View Market Depth

No.	Vol.	Price($)
28	20602035	0.004
38	27574272	0.003
18	15950508	0.002
12	54150000	0.001
0	0	0.000

Price($)	Vol.	No.
0.005	14012739	13
0.006	9198729	10
0.007	3100000	2
0.008	8685291	7
0.009	1037990	2

Last trade - 16.10pm 04/07/2025 (20 minute delay)

CHM (ASX) Chart

CHIMERIC THERAPEUTICS LIMITED - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories